APH
AMPHENOL CORP /DE/Evidence as of 2026-09-02Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.8 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The desk’s evidence paints a constructive picture (Constructive +0.8 of a possible +2; was +0.8 before debate) driven by a steady sequence of quarterly growth across top-line and margin dollars. Revenue rose each reported fiscal quarter from fiscal Q1 2025 (fiscal quarter ended 2025-04-22) revenue $ 4,811,000,000 to fiscal Q2 2026 (fiscal quarter ended 2026-07-28) revenue $ 8,758,100,000, and gross profit increased in the same sequence from $ 1,644,000,000 to $ 3,548,000,000, producing expanding absolute gross profit alongside revenue growth. Operating income advanced to $ 2,584,600,000 in fiscal Q2 2026, diluted EPS and net income rose on the same cadence to diluted EPS $ 1.37 /share and net income $ 1,769,200,000 in fiscal Q2 2026, and the company is reported as modestly net cash on the balance-sheet dates provided (cash $ 4,729,400,000; long-term debt dated earlier at $ 3,239,300,000).
Market signals are also constructive: price sits above the 50- and 200-day simple moving averages (price vs SMA50 +1.4%, vs SMA200 +12.6%) with a golden cross, momentum metrics are strongly positive (3-month +10.1%, 6-month +26.4%, 12-1 +54.4%), and relative strength versus SPY is positive. Valuation ratios are rich on trailing bases (P/FCF 89.67, EV/EBITDA 22.69, P/E 41.63) and the implied FCF growth rate embedded in today’s price is 50.44% per year.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenue has increased each reported fiscal quarter in the series: fiscal Q1 2026 (2026-01-01 to 2026-03-31) revenue 7,620,100,000 USD, fiscal Q2 2026 (2026-04-01 to 2026-06-30) revenue 8,758,100,000 USD (and earlier quarters: fiscal Q3 2025 (2025-07-01 to 2025-09-30) 6,194,400,000 USD; fiscal Q2 2025 (2025-04-01 to 2025-06-30) 5,650,300,000 USD; fiscal Q1 2025 (2025-01-01 to 2025-03-31) 4,811,000,000 USD).
XBRL companyfacts · 0001104659-26-054128Gross profit as reported rose across the same sequence of fiscal quarters: fiscal Q1 2026 gross profit 2,804,200,000 USD, fiscal Q2 2026 gross profit 3,548,000,000 USD (and earlier: fiscal Q3 2025 2,359,300,000 USD; fiscal Q2 2025 2,053,300,000 USD; fiscal Q1 2025 1,644,000,000 USD), implying expanding absolute gross profit alongside revenue growth.
XBRL companyfacts · 0001104659-26-054128Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
Momentum signals are strongly positive: 3-month +10.1%, 6-month +26.4% (85th percentile of 547), and a 12-1 momentum of +54.4% (84th percentile of 547).
Moneyta signal set · 2026-09-01weakened in debatePrice is above both short- and long-term moving averages: price vs SMA50 +1.4% and price vs SMA200 +12.6%, with a golden cross present.
Moneyta signal set · 2026-09-01Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02T13:45:47.228469+00:00, APH is held in the iShares Core S&P 500 ETF (IVV) at a weight of 0.34% of that fund.
ETF constituents · market dataPresence in a major S&P 500 index ETF (IVV) indicates APH provides passive index exposure to investors tracking the S&P 500 as of 2026-09-02T13:45:47.228469+00:00.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Several outlets published pieces framing Amphenol in the context of sector performance, asking whether computer and technology stocks are lagging Amphenol this year.
News · zacks.com · 2026-09-02A different outlet ran the same sector-comparison theme, showing the story is carried by more than one distinct outlet.
News · finance.yahoo.com · 2026-09-02Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The implied free cash flow (FCF) growth rate that today's price would justify is 50.44% per year, per the valuation inputs and assumptions.
Valuation inputs · SEC XBRL + stored EOD closePrice-to-free-cash-flow (P/FCF) on a trailing twelve-month basis is 89.67.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
The provided company-reported fundamentals show a clear, well-sourced sequence of quarterly revenue, gross profit, operating income, and EPS gains (fundamentals-0 through fundamentals-4), which together constitute strong, internally consistent evidence of improving operating performance over the reported periods. Market signals (market-0, market-1, market-2) corroborate a positive market reaction: above-average momentum, price above key moving averages, and strong relative strength versus the S&P 500, all of which are objective, quantifiable indicators. Valuation and volatility flags (valuation-0 through valuation-3, market-3) are legitimate concerns but rest on snapshots and ratios that do not negate the documented earnings and cash-flow levels (valuation-4, valuation-5) or the repeated quarterly improvements; the valuation metrics appear to reflect high market expectations rather than a failure of fundamentals. News items that present lower intrinsic-value estimates or technical skepticism (news-3, news-4) represent one analyst viewpoint and short-term framing, which is weaker relative to the direct company filings showing sequential improvement. Taken jointly, the strongest, highest-strength evidence is the company filing data demonstrating expanding revenue, gross profit, and operating income across multiple quarters, supported by positive market momentum and ample cash on the balance sheet.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.36
28 surviving claims rest on 13 distinct sources; the heaviest analyst carries 25% of them, and 93% of what the desk raised survived the debate.
The evidence set is moderately concentrated: 28 surviving claims draw on 13 sources, with one analyst contributing a quarter of the claims and a very high 93% survival rate from the desk debate. That combination raises caution — the high survival rate suggests the claims were rarely challenged internally, while the single-analyst concentration and limited source breadth mean individual biases or errors could disproportionately affect the read.
Peer context · computed, not argued
12-1 momentum ranks 2nd of 2 in Electronic Components (as of 2026-09-01).
6-month relative strength ranks 1st of 2 in Electronic Components (as of 2026-09-01).
90-day volatility ranks 2nd of 2 in Electronic Components (as of 2026-09-01).
dividend yield ranks 2nd of 2 in Electronic Components (as of 2026-09-01).
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
12 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+1.2 to the score
1 signal set
Moneyta signal set
Computed from our own end-of-day price history and ranked against the whole research universe. No AI involved.
Read by Nash+0.2 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+1.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on APH Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.